Follicle Stimulating Hormone Global Market Report 2025

Description

Follicle-stimulating hormone (FSH) is a hormone secreted by the pituitary gland, playing a crucial role in sexual maturation and reproduction. It influences the functioning of the testicles and ovaries, particularly in regulating egg production in the ovaries and the menstrual cycle.

The primary types of follicle-stimulating hormones include recombinant FSH and urinary FSH. Recombinant FSH is a form of FSH produced using recombinant DNA technology, as opposed to being derived from natural sources such as urine. These hormones find application in various areas, including infertility treatment, assisted reproductive technology (ART), and other medical contexts. They are utilized by diverse end-users, including infertility centers, hospitals, and similar institutions.

The follicle stimulating hormone market research report is one of a series of new reports from The Business Research Company that provides follicle stimulating hormone market statistics, including follicle stimulating hormone industry global market size, regional shares, competitors with a follicle stimulating hormone market share, detailed follicle stimulating hormone market segments, market trends and opportunities, and any further data you may need to thrive in the follicle stimulating hormone industry. This follicle stimulating hormone market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The follicle stimulating hormone market size has grown strongly in recent years. It will grow from $2.03 billion in 2024 to $2.14 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to increased prevalence of hormonal disorders, growing demand for fertility treatment, expansion of FSH indications, market entry of new FSH products, growing demand for safe and effective contraceptive options

The follicle stimulating hormone market size is expected to see strong growth in the next few years. It will grow to $2.64 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to widening therapeutic applications, rising demand for combination therapy, growing need for effective contraceptive options, aging population and related healthcare needs, market expansion in key regions. Major trends in the forecast period include advanced biosimilar FSH products, regulatory approvals and market access, technological advancements in FSH production and delivery, growing need for effective contraceptive options.

The anticipated growth in the follicle-stimulating hormone market is expected to be propelled by the increasing prevalence of infertility. Infertility, a condition impacting the male or female reproductive system, is characterized by the inability to conceive after 12 months or more of frequent, unprotected sexual contact. Follicle-stimulating hormone plays a crucial role in encouraging egg development in the ovaries and regulating the menstrual cycle in females. In men, it promotes testicular growth and assists in the production of a protein essential for male fertility by supporting the development of healthy sperm cells. Notably, as of April 2023, the World Health Organization reported that infertility affected approximately 1 in 6 adults globally, accounting for around 17.5% of the adult population. Moreover, data from the Australian Bureau of Statistics in October 2023 indicated a 3% decrease in recorded births in 2022, with an overall fertility rate of 1.63 births per woman. Consequently, the increasing prevalence of infertility is a driving force behind the growth of the follicle-stimulating hormone market.

The growing adoption of assisted reproductive technology (ART) is anticipated to drive the expansion of the follicle-stimulating hormone market in the coming years. ART refers to medical procedures or practices that assist individuals or couples in conceiving when traditional methods have not been successful. The use of follicle-stimulating hormone in ART is a well-established therapy aimed at improving the chances of successful pregnancies for those facing reproductive challenges. For example, in March 2024, the U.S. Department of Health and Human Services reported that the use of ART increases with maternal age. In 2023, 9% of live births among women aged 40-45 were achieved through ART, with that number rising to nearly one-third for women aged 45 and older. Additionally, ART usage varies by region across the U.S. As a result, the increasing adoption of assisted reproductive technology is significantly impacting the follicle-stimulating hormone market.

Product innovations are a significant trend gaining traction in the follicle-stimulating hormone market. Leading companies in this sector are concentrating on developing innovative products to enhance their market position. For instance, in July 2024, Proov, a U.S.-based women's health company, introduced the Proov Empower Perimenopause Testing System. Proov Empower provides comprehensive and personalized insights into how a woman's changing hormones impact her overall health and wellness. This non-invasive, multi-time point urine test measures four key hormones-FSH, estrogen marker E1G, progesterone marker PdG, and LH-that affect symptoms and the perimenopause experience. By facilitating periodic retesting, Proov Empower enables women to monitor hormone fluctuations and symptoms, acting as a valuable resource during the transition to menopause.

Major companies in the follicle-stimulating hormone market are also investing in the development of groundbreaking products such as estrogen-based pills to augment their product offerings and gain a competitive edge. Estrogen-based pills, containing the essential hormone for the growth and management of the female reproductive system, represent a notable innovation. In August 2022, Myovant Sciences Ltd., a UK-based biopharmaceutical company, and Pfizer Inc., a US-based pharmaceutical and biotechnology firm, announced the US Food and Drug Administration (FDA) authorization for MYFEMBREE (relugolix 40 mg, estradiol 1 mg, and norethindrone acetate 0.5 mg) as a one-pill treatment. MYFEMBREE serves as a once-daily medication for the treatment of moderate to severe pain caused by endometriosis in premenopausal women for up to 24 months. Additionally, it is authorized for premenopausal women experiencing excessive menstrual bleeding due to uterine fibroids. Myovant and Pfizer intend to jointly market MYFEMBREE in the United States.

In September 2024, Organon China, a healthcare company based in China, partnered with Shanghai Bao Pharmaceutical to develop SJ02, a Long-Acting FSH currently in the BLA process. This innovative investigational asset targets the assisted reproductive technology (ART) market in mainland China. Through this partnership, Organon is advancing its "In China, for China" strategy while expanding its fertility portfolio. By collaborating with leading innovators in China, Organon aims to accelerate advancements in ART and offer additional fertility options to millions of Chinese families. Shanghai Bao Pharmaceutical is a provider of follicle-stimulating hormone (FSH) based in China.

Major companies operating in the follicle stimulating hormone market include Pfizer Inc., Novartis AG, Abbott Laboratories, Sanofi S.A., Boehringer Ingelheim GmbH, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Cipla Ltd., Ferring Pharmaceuticals Inc., Lupin Limited, Zydus Lifesciences Limited, Livzon Pharmaceutical Group Inc., Emcure Pharmaceuticals Ltd., LG Chem's life sciences, IBSA Group, Bharat Serums and Vaccines Limited, Anhui Anke Biotechnology Group Co. Ltd., Taj Pharmaceuticals Ltd., Genpharm Inc., Cadwell Laboratories Inc., Creative BioMart, Lee Biosolutions Inc., Trumac Healthcare, Midas Pharma GmbH, Biogenix Inc. Pvt. Ltd., Shanghai Techwell Biopharmaceutical Co. Ltd.

North America was the largest region in the follicle stimulating hormone market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the follicle stimulating hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the follicle stimulating hormone market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The follicle-stimulating hormone market consists of sales of luteinizing hormone (LH), chorionic gonadotropin (CG), and thyroid-stimulating hormone. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Follicle Stimulating Hormone Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on follicle stimulating hormone market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for follicle stimulating hormone ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The follicle stimulating hormone market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Recombinant FSH; Urinary FSH
2) By Application: Infertility Treatment; Assisted Reproductive Technology (ART); Other Applications
3) By End-Users: Infertility Center; Hospitals; Other End-Users
Subsegments:
1) By Recombinant FSH: Pure Recombinant FSH; Mixed Recombinant FSH Formulations
2) By Urinary FSH: Purified Urinary FSH; Urinary FSH Combined With Other Hormones
Companies Mentioned: Pfizer Inc.; Novartis AG; Abbott Laboratories; Sanofi S.A.; Boehringer Ingelheim GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r24944

1. Executive Summary

2. Follicle Stimulating Hormone Market Characteristics

3. Follicle Stimulating Hormone Market Trends And Strategies

4. Follicle Stimulating Hormone Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Follicle Stimulating Hormone Growth Analysis And Strategic Analysis Framework

5.1. Global Follicle Stimulating Hormone PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Follicle Stimulating Hormone Market Growth Rate Analysis
5.4. Global Follicle Stimulating Hormone Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Follicle Stimulating Hormone Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Follicle Stimulating Hormone Total Addressable Market (TAM)

6. Follicle Stimulating Hormone Market Segmentation

6.1. Global Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Recombinant FSH
Urinary FSH
6.2. Global Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infertility Treatment
Assisted Reproductive Technology (ART)
Other Applications
6.3. Global Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infertility Center
Hospitals
Other End-Users
6.4. Global Follicle Stimulating Hormone Market, Sub-Segmentation Of Recombinant FSH, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pure Recombinant FSH
Mixed Recombinant FSH Formulations
6.5. Global Follicle Stimulating Hormone Market, Sub-Segmentation Of Urinary FSH, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Purified Urinary FSH
Urinary FSH Combined With Other Hormones

7. Follicle Stimulating Hormone Market Regional And Country Analysis

7.1. Global Follicle Stimulating Hormone Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Follicle Stimulating Hormone Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Follicle Stimulating Hormone Market

8.1. Asia-Pacific Follicle Stimulating Hormone Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Follicle Stimulating Hormone Market

9.1. China Follicle Stimulating Hormone Market Overview
9.2. China Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Follicle Stimulating Hormone Market

10.1. India Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Follicle Stimulating Hormone Market

11.1. Japan Follicle Stimulating Hormone Market Overview
11.2. Japan Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Follicle Stimulating Hormone Market

12.1. Australia Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Follicle Stimulating Hormone Market

13.1. Indonesia Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Follicle Stimulating Hormone Market

14.1. South Korea Follicle Stimulating Hormone Market Overview
14.2. South Korea Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Follicle Stimulating Hormone Market

15.1. Western Europe Follicle Stimulating Hormone Market Overview
15.2. Western Europe Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Follicle Stimulating Hormone Market

16.1. UK Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Follicle Stimulating Hormone Market

17.1. Germany Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Follicle Stimulating Hormone Market

18.1. France Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Follicle Stimulating Hormone Market

19.1. Italy Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Follicle Stimulating Hormone Market

20.1. Spain Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Follicle Stimulating Hormone Market

21.1. Eastern Europe Follicle Stimulating Hormone Market Overview
21.2. Eastern Europe Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Follicle Stimulating Hormone Market

22.1. Russia Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Follicle Stimulating Hormone Market

23.1. North America Follicle Stimulating Hormone Market Overview
23.2. North America Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Follicle Stimulating Hormone Market

24.1. USA Follicle Stimulating Hormone Market Overview
24.2. USA Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Follicle Stimulating Hormone Market

25.1. Canada Follicle Stimulating Hormone Market Overview
25.2. Canada Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Follicle Stimulating Hormone Market

26.1. South America Follicle Stimulating Hormone Market Overview
26.2. South America Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Follicle Stimulating Hormone Market

27.1. Brazil Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Follicle Stimulating Hormone Market

28.1. Middle East Follicle Stimulating Hormone Market Overview
28.2. Middle East Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Follicle Stimulating Hormone Market

29.1. Africa Follicle Stimulating Hormone Market Overview
29.2. Africa Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Follicle Stimulating Hormone Market Competitive Landscape And Company Profiles

30.1. Follicle Stimulating Hormone Market Competitive Landscape
30.2. Follicle Stimulating Hormone Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Follicle Stimulating Hormone Market Other Major And Innovative Companies

31.1. Merck KGaA
31.2. Teva Pharmaceutical Industries Ltd.
31.3. Sun Pharmaceutical Industries Ltd.
31.4. Intas Pharmaceuticals Ltd.
31.5. Cipla Ltd.
31.6. Ferring Pharmaceuticals Inc.
31.7. Lupin Limited
31.8. Zydus Lifesciences Limited
31.9. Livzon Pharmaceutical Group Inc.
31.10. Emcure Pharmaceuticals Ltd.
31.11. LG Chem's life sciences
31.12. IBSA Group
31.13. Bharat Serums and Vaccines Limited
31.14. Anhui Anke Biotechnology Group Co. Ltd.
31.15. Taj Pharmaceuticals Ltd.

32. Global Follicle Stimulating Hormone Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Follicle Stimulating Hormone Market

34. Recent Developments In The Follicle Stimulating Hormone Market

35. Follicle Stimulating Hormone Market High Potential Countries, Segments and Strategies

35.1 Follicle Stimulating Hormone Market In 2029 - Countries Offering Most New Opportunities
35.2 Follicle Stimulating Hormone Market In 2029 - Segments Offering Most New Opportunities
35.3 Follicle Stimulating Hormone Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer